|
M6PR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.037800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.997370E-01 |
| Normal-vs-Stage2 |
5.929700E-02 |
| Normal-vs-Stage3 |
1.312400E-02 |
| Normal-vs-Stage4 |
1.712970E-01 |
| Stage1-vs-Stage2 |
1.972030E-01 |
| Stage1-vs-Stage3 |
3.761600E-02 |
| Stage1-vs-Stage4 |
3.556200E-01 |
| Stage2-vs-Stage3 |
2.894400E-01 |
| Stage2-vs-Stage4 |
9.715200E-01 |
| Stage3-vs-Stage4 |
4.443400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.834340E-02 |
| Normal-vs-AfricanAmerican |
1.819930E-03 |
| Normal-vs-Asian |
2.414200E-01 |
| Caucasian-vs-AfricanAmerican |
1.707780E-01 |
| Caucasian-vs-Asian |
3.639800E-01 |
| AfricanAmerican-vs-Asian |
5.051200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.311600E-02 |
| Normal-vs-Female |
6.19519999999207E-05 |
| Male-vs-Female |
1.216050E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.338820E-01 |
| Normal-vs-Extreme_Weight |
6.099000E-01 |
| Normal-vs-Obese |
7.116400E-03 |
| Normal-vs-Extreme_Obese |
5.304000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.008400E-01 |
| Normal_Weight-vs-Obese |
2.597800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.177000E-01 |
| Extreme_Weight-vs-Obese |
2.788200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.768800E-01 |
| Obese-vs-Extreme_Obese |
2.691900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.524300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.605480E-04 |
| Normal-vs-Age(61-80Yrs) |
2.646200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.076400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.605600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.989900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.564400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.957000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.107030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.017400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.645700E-02 |
| Normal-VS-Type2 PRCC |
2.560400E-02 |
| Normal-VS-KIRP CIMP |
2.511500E-02 |
| Normal-VS-Unclassified PRCC |
6.899500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.116200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.084430E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.040000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.050400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.690000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.667200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.097830E-01 |
| Normal-vs-N1 |
9.583600E-03 |
| Normal-vs-N2 |
3.081600E-01 |
| N0-vs-N1 |
1.472000E-01 |
| N0-vs-N2 |
3.022400E-01 |
| N1-vs-N2 |
7.543800E-01 |
|
|
